Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2017
At a glance
- Drugs UV 4
- Indications Viral infections
- Focus Adverse reactions
- Sponsors Emergent BioSolutions
- 21 Jun 2017 Status changed from suspended to discontinued.
- 22 Feb 2017 Status changed from recruiting to suspended due to pending SMC review and recommendation
- 10 Jan 2017 Planned End Date changed from 1 Jul 2017 to 1 Jun 2018.